TABLE 1

Patient Characteristics, Tumoral Tracer Uptake, and Proliferation Fraction (Ki-67 Index)

Patient no.	Age (y)	Sex	Histopathology finding	TNM	SUV
										¹⁸F-FLT			¹⁸F-FDG
										Mean	Maximum	Mean	Maximum
1	57	F	Non–small cell lung cancer	T1 N1 M0	5.6	8.7	6.3	11.3	65
2	53	M	Non–small cell lung cancer	T2 N1 M0	4.0	5	7.6	13.5	41
3	77	F	Non–small cell lung cancer	T2 N1 M0	4.0	5.3	10.6	22.7	43
4	71	F	Non–small cell lung cancer	T2 N1 M0	2.9	4.4	4.13	6.5	35
5	75	M	Non–small cell lung cancer	T2b N0 M0	3.1	5.7	6.5	12.5	54
6	53	F	Non–small cell lung cancer	T2 N1 M0	Neg	Neg	2.6	3.1	10
7	61	M	Non–small cell lung cancer	T3 N0 M0	4.9	6.8	5.1	7.3	45
8	76	M	Non–small cell lung cancer	T4 N2 M0	3.1	5.2	7.9	12.3	35
9	55	M	Non–small cell lung cancer	T2 N2 MX	3.9	5.6	6.8	11	40
10	62	F	Non–small cell lung cancer	TX N0 M0	2.3	3.3	4.6	7.3	10
11	55	M	Non–small cell lung cancer	T1 N1 M0	1.1	1.3	5.5	10.1	12
12	56	F	Non–small cell lung cancer	T3 N3 M0	6.4	10.4	4.8	8.3	70
13	67	M	Non–small cell lung cancer (carcinoma in situ)	T1 N0 M0	Neg	Neg	Neg	Neg	32
14	66	M	Small cell lung cancer	T4 N2 M0	1.7	2.4	7.3	12.7	20
15	68	M	Met from colorectal cancer	rTX N0 M1	Neg	Neg	3.7	6.8	12
16	51	M	Met from renal cell carcinoma	rTX N0 M1	2.1	3.4	6.7	12.1	23
17	65	M	Met from renal cell carcinoma	rTX N0 M1	1.3	1.9	1.0	1.4	10
18	37	F	Met from osteosarcoma	TX N0 M1	0.8	1	1.5	1.5	1
19	75	M	Bronchiolitis	—	Neg	Neg	6.9	10.3	0
20	76	M	2 × 3 cm nodule, benign lesion indicated by clinical course	—	Neg	Neg	3.0	4.3	0
21	51	F	Tuberculoma	—	Neg	Neg	1.1	1.8	5
22	59	M	Bronchiolitis	—	Neg	Neg	Neg	Neg	0
23	69	M	Bronchiolitis	—	Neg	Neg	Neg	Neg	0
24	67	M	1 × 2 cm nodule, benign lesion indicated by clinical course	—	Neg	Neg	2.2	2.9	0
25	55	F	Fibroma	—	Neg	Neg	Neg	Neg	0
26	56	M	Chondroma	—	Neg	Neg	Neg	Neg	0